细胞和基因治疗制造服务市场规模预计将从 2022 年的 75.8197 亿美元增至 2030 年的 267.249 亿美元。预计 2022-2030 年期间市场复合年增长率将达到 17.1%。细胞和基因治疗制造服务自动化可能仍是市场的主要趋势。
细胞和基因治疗制造服务市场分析
近年来,外包细胞和基因制造行业经历了显著的扩张和变化。随着细胞和基因疗法的进步,药物创新公司越来越依赖服务提供商来满足其制造需求。外包使创新者能够利用合同开发和制造组织 (CDMO) 的专业知识和能力来降低成本并加快上市时间。过去五年来,细胞和基因疗法制造的格局发生了变化,转向更复杂的平台,允许扩大规模、提高自动化程度和增强质量体系,从而塑造了合同制造行业。随着每年市场上获批的细胞和基因疗法产品数量不断增加,增强流程的需求变得越来越重要。
细胞和基因治疗制造服务市场概览
由于竞争审批的新型生物制药产品数量激增,公共和私人资助的合同生物制药制造均有所增加。因此,在老牌行业参与者试图保持其地位和领先地位的同时,新组织也致力于为细胞和基因治疗提供制造服务。许多地区的医疗保健政策现在优先考虑制造各种药物(小分子)产品的能力。此外,许多地区都转向大分子生物制造、重组疗法和日益复杂的生物制剂。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
细胞和基因治疗制造服务市场:
复合年增长率(2022 - 2030 年)17.1%- 2022 年市场规模
75.8197 亿美元 - 2030 年市场规模
267.249 亿美元
市场动态
- 细胞和基因治疗制造外包增加
- 技术转让扩大生物制药企业的能力biopharmaceutical players
- 资源丰富的服务提供商的出现
关键人物
- 赛默飞世尔科技公司 Fisher Scientific Inc
- 默克公司KGaA
- 查尔斯河实验室国际公司
- 龙沙集团 Group AG
- 药明康德 AppTec Co Ltd
- 康泰伦特公司 Inc
- 宝生物公司
- 尼康公司
- 富士胶片控股公司
- 国家复原力公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 细胞疗法
- 基因治疗
- 癌症
- 骨科
- 临床制造
- 商业制造
- 制药
- 生物科技公司
- 合同研究组织
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
细胞和基因治疗制造服务市场驱动因素和机遇
细胞和基因治疗制造需求增加有利于市场增长
细胞和基因治疗制造服务取得了重大的治疗进展,这得益于细胞治疗研究活动的不断增长。该行业正努力扩大其制造规模,并让更广泛的人群能够获得该服务,同时强调先进治疗药物 (ATMP) 的优势。个性化医疗的日益复杂要求开发制造能力,以满足需求并保证患者能够获得这些创新治疗。由于全球产量的增加,合同制造现在有了更多的选择。来自公共和私人来源的对新批准的生物制药产品以及合同生物制药制造的资金都有所增加。全球组织提供细胞和基因治疗的制造服务,而成熟的行业参与者则努力维持其运营。因此,对细胞治疗制造发展的新兴关注可能会推动市场的增长。
主要参与者的战略举措
由于批准和投资的增加,在临床前、临床和商业阶段制造疗法的需求日益增加。关键参与者正在进行战略发展投资,这开辟了大量市场机会。作为对细胞和基因治疗制造服务需求不断增长的一个例子,百时美施贵宝和初创公司 Cellares 于 2024 年 5 月签署了一项 3.8 亿美元的交易。2023 年 8 月,Cellares 完成了 2.55 亿美元的 C 轮融资,BMS 是投资者之一。Cellares 将为 BMS 生产嵌合抗原受体 (CAR) T 细胞治疗。BMS 将根据协议条款在 Cellares 的自动化细胞治疗制造机或 Cell Shuttle 机器中预留空间。利用 BMS 出售所得的资金,Cellares 打算在美国、欧洲和日本开设更多地点,除了经营旧金山和新泽西的地点。
细胞和基因治疗制造服务市场报告细分分析
有助于得出细胞和基因治疗制造服务市场分析的关键部分是类型、适应症、应用和最终用户。
- 根据类型,细胞和基因治疗制造服务市场分为细胞治疗和基因治疗。细胞治疗进一步细分为自体治疗和同种异体治疗。基因治疗进一步细分为病毒和非病毒载体。
- 根据适应症,市场分为癌症、骨科和其他。2022 年,癌症领域占据了最大的市场份额。
- 根据应用,市场分为临床制造和商业制造。商业制造领域在 2022 年占据了最大的市场份额。
- 根据最终用户,市场分为制药和生物技术公司以及合同研究组织 (CRO)。制药和生物技术公司部门在 2022 年占据了最大的市场份额。
细胞和基因治疗制造服务市场份额(按地区)分析
细胞和基因治疗制造服务市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。
由于对这些产品的需求不断增长,与细胞和基因治疗相关的制造服务市场预计将扩大。这一增长与初创企业数量的增加、研发活动的增加以及美国和加拿大对细胞和基因治疗制造设施建设的投资增加有关。
此外,在预测期内,亚太市场以强劲的复合年增长率大幅增长。这种增长可以归因于多种因素,包括对先进治疗解决方案的需求不断增长、有利的监管环境以及对研发活动的日益重视。此外,在预测期内,预计亚太市场将受到医疗基础设施扩张和旨在刺激研究活动的投资增加的推动。
细胞和基因治疗制造服务市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 75.8197亿美元 |
2030 年的市场规模 | 267.249 亿美元 |
全球复合年增长率(2022 - 2030 年) | 17.1% |
史料 | 2020-2021 |
预测期 | 2022-2030 |
涵盖的领域 | 按类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
细胞和基因治疗制造服务市场新闻和最新发展
细胞和基因治疗制造服务市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下列出了细胞和基因治疗制造服务市场的一些发展情况:
- 细胞和基因治疗行业两家领先的合同开发和制造组织 (CDMO) RoslinCT 和 Lykan Bioscience 宣布整合,创建一家以 RoslinCT 品牌运营的统一企业。此次整合由全球投资公司 GHO Capital 促成,旨在成为先进细胞和基因治疗 CDMO 市场的主导者。(来源:RoslinCT,新闻稿,2023 年 6 月)
- 辛辛那提儿童医院医疗中心和研究服务提供商 CTI 临床试验与咨询服务公司已同意组建一家公司,专注于为生物技术和制药行业提供细胞和基因治疗制造服务。(来源:辛辛那提儿童医院医疗中心,新闻稿,2021 年 12 月)
细胞和基因治疗制造服务市场报告覆盖范围和交付成果
“细胞和基因治疗制造服务市场规模和预测(2020-2030)”报告对以下领域进行了详细的市场分析:
- 细胞和基因治疗制造服务市场规模以及全球、区域和国家层面所有关键细分市场的预测
- 细胞和基因治疗制造服务市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
- 详细的 PEST/波特五力分析和 SWOT 分析
- 细胞和基因治疗制造服务市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
- 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及细胞和基因治疗制造服务市场的最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Microplate Reader Market
- Fish Protein Hydrolysate Market
- Terahertz Technology Market
- Collagen Peptides Market
- Smart Mining Market
- Real-Time Location Systems Market
- Artificial Intelligence in Healthcare Diagnosis Market
- Diaper Packaging Machine Market
- Legal Case Management Software Market
- Glycomics Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the cell and gene therapy manufacturing services market in 2022
Key factors driving the market are increase in demand for cell and gene therapy manufacturing and the emergence of new startup service providers.
Automation of manufacturing services for cell and gene therapy is likely to remain a key trend in the market.
Thermo Fisher Scientific Inc, Merck KGaA, Charles River Laboratories International Inc, Lonza Group AG, WuXi AppTec Co Ltd, Catalent Inc, Takara Bio Inc, Nikon Corp, FUJIFILM Holdings Corp, National Resilience Inc, Oxford BioMedica Plc.
The market is expected to register a CAGR of 17.1% during 2022–2030.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Cell and Gene Therapy Manufacturing Services Market
- Thermo Fisher Scientific Inc
- Merck KGaA
- Charles River Laboratories International Inc
- Lonza Group AG
- WuXi AppTec Co Ltd
- Catalent Inc
- Takara Bio Inc
- Nikon Corp
- FUJIFILM Holdings Corp
- National Resilience Inc,
- Oxford BioMedica Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.